Delivery included to the United States

Hybrid SPECT/CT Imaging With 99MTc-MIBI

Hybrid SPECT/CT Imaging With 99MTc-MIBI

Paperback (24 Nov 2022)

Save $5.54

  • RRP $47.19
  • $41.65
Add to basket

Includes delivery to the United States

10+ copies available online - Usually dispatched within 7 days

Publisher's Synopsis

Metastable Technetium 99-labeled Methoxy-IsoButyl-Isonitrile (99mTc-MIBI) single-photon emission computed tomography (SPECT/CT) is recommended for the preoperative workup of hyperparathyroidism to guide minimally invasive surgery. Nevertheless, the introduction of a CT scan, even at low dose, increases the total radiation dose delivered to the patient. The aim was to evaluate the additional effective dose delivered by CT to 99mTc-MIBI parathyroid scintigraphy. This prospective study included 100 adults with primary hyperparathyroidism who received 99mTc-MIBI SPECT/CT. The mean age was 55.6 years with a M/F sex ratio of 0.28. The effective scintigraphic dose was 9.77 mSv. The mean CT effective dose was 1.77mSv. The mean total effective dose from the hybrid examination was 11.54 mSv and ranged from 10.66 to 12.88 mSv. The contribution of the additional radiation induced by CT ranged from 8.3 to 24.1% with a mean of 15%. This dose is not negligible. But taking into account the benefit of hybrid imaging, this additional radiation is still justifiable.

Book information

ISBN: 9786205387368
Publisher: KS Omniscriptum Publishing
Imprint: Our Knowledge Publishing
Pub date:
Language: English
Number of pages: 68
Weight: 113g
Height: 229mm
Width: 152mm
Spine width: 4mm